The purpose of this study is to determine if mupirocin 2% in polyethylene glycol (PEG)
ointment [Treatment Arm] is effective in preventing moderate to severe re-infection with
Staphylococcus aureus compared with treatment with polyethylene glycol (PEG) ointment
[Placebo Arm].
The purpose of this study is to determine if mupirocin 2% in polyethylene glycol (PEG)
ointment [Treatment Arm] is effective in preventing moderate to severe re-infection with
Staphylococcus aureus compared with treatment with polyethylene glycol (PEG) ointment
[Placebo Arm].
The purpose of this study is to determine if mupirocin 2% in polyethylene glycol (PEG)
ointment [Treatment Arm] is effective in preventing moderate to severe re-infection with
Staphylococcus aureus compared with treatment with polyethylene glycol (PEG) ointment
[Placebo Arm].
The purpose of this study is to determine if mupirocin 2% in polyethylene glycol (PEG)
ointment [Treatment Arm] is effective in preventing moderate to severe re-infection with
Staphylococcus aureus compared with treatment with polyethylene glycol (PEG) ointment
[Placebo Arm].
Prophylaxis With Intranasal Mupirocin for Prevention of S. Aureus Infections
Completed
GlaxoSmithKline
Phase 4
2002-11-01
In order to evaluate the effect of eliminating nasal carriage by mupirocin prophylaxis on
subsequent Staphylococcus aureus infection, a prospective randomized trial was performed
particularly including patients with predisposing risk factors for S. aureus infections.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
